this paper reviews the safety data on bromocriptine administration for 1 to 10 years at daily doses of 1.25 to 80 mg in over 1100 patients with pituitary hormone overproduction ( mainly from prolactinomas and growth-hormone producing adenomas ) , at daily doses of 3.75 to 170 mg in over 700 patients with parkinson 's disease , and at daily doses of 2.5 to 20 mg in 28 patients with various other conditions .
C0006230
bromocriptine
C0001430
adenomas